• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: May 2019

Animal Health

Call to Action for Veterinary Industry to Support Microbiome-based Veterinary Products

May 30, 2019 Microbiome Times

Emerging scientific developments have shown that microbiome-based medicinal products do not only represent a paradigm shift in human medicine, but also in veterinary medicine. With the global initiatives to curtail the indiscriminate and irresponsible use […]

Editor's Choice

New Findings from Human Microbiome Project Reveal how Microbiome is Disrupted During IBD

May 30, 2019 Microbiome Times

A new study led by researchers from Harvard T.H. Chan School of Public Health and the Broad Institute of MIT and Harvard is the first to have observed the complex set of chemical and molecular […]

Editor's Choice

Biotech Focus: Live Lactobacilli as a Solution to Improve Skin Health

May 28, 2019 Microbiome Times

Topical application of beneficial lactobacilli and potentially other ‘live biotherapeutic products’ (LBPs) show great potential as an alternative strategy to tackle skin care problems related to disturbance of the skin microbiome, providing alternatives to the […]

Finance

Crown Laboratories Acquires Xycrobe™ Therapeutics, Inc.

May 24, 2019 Microbiome Times

Crown Laboratories, Inc. (“Crown”), a leading, fully integrated skin care company, announced it has acquired Xycrobe Therapeutics, Inc. (“Xycrobe”). Xycrobe’s technology focuses on utilizing the ubiquitous nature of skin microbes by turning them into vehicles […]

Finance

Synlogic Announces New Clinical Collaboration with Roche

May 22, 2019 Microbiome Times

Synlogic, Inc., (Nasdaq: SYBX) a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, today announced a new clinical collaboration with Roche (SIX:RO, ROG), to explore Synlogic’s Synthetic Biotic™ medicine, SYNB1891, […]

Finance

MaaT Pharma Expands Patent Portfolio with Three Granted Patents

May 22, 2019 Microbiome Times

MaaT Pharma announced today that the Institut National de la Propriété Industrielle (INPI), the French Patent Office, has issued three new patents to the company covering its sample collection device and the overall processes associated […]

Editor's Choice

IMM-ETG: A New European Initiative for Intestinal Microbiome Medicinal Products

May 21, 2019 Alice Rouanet

Caelus Health, EnteroBiotix, Ferring Pharmaceuticals, and MaaT Pharma, in coordination with the Pharmabiotic Research Institute (PRI), are working in collaboration within the ‘Intestinal Microbiome-based Medicines European Task Group (IMM-ETG)’ to propose a harmonised, pan-European, regulatory […]

Pharma & Human Health

Human gut microbiome physiology can now be studied in vitro using Organ Chip technology

May 20, 2019 Benjamin Boettner

The human microbiome, the huge collection of microbes that live inside and on our body, profoundly affects human health and disease. The human gut flora in particular, which harbor the densest number of microbes, not […]

Pharma & Human Health

Healthy Directions introduces LifeBiome™ – a new line of innovative digestive health supplements

May 17, 2019 Microbiome Times

For over 25 years, Healthy Directions has been forging a path to better health with innovative products developed by leading health experts. Today, they announce the new LifeBiome™ product line, inspired by nature and uniquely […]

Pharma & Human Health

BioCompute and WHISE-Embleema Launch Framework for FDA Drug Submissions

May 15, 2019 Microbiome Times

BioCompute, a collaboration between The George Washington University and the FDA to improve communication of bioinformatics pipelines, today announced a new guidance for life sciences companies using next generation sequencing (NGS) analysis as part of […]

Finance

Vedanta Biosciences Closes Extended $45.5 Million Series C Financing

May 13, 2019 Microbiome Times

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, has raised an additional $18.5 million as an extension of its Series C […]

Posts navigation

1 2 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
  • Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet
    April 3, 2025
  • Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation
    March 25, 2025
  • Dynamic Microbiome Abundance Profiling: A new tool to solve challenges in microbiome analysis
    March 5, 2025
  • Scientists decode diet from stool DNA – no questions asked
    February 24, 2025
sign up

Sign up to the Microbiome Times newsletter